{
    "code": "02003104",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02003104",
    "time": "2020-02-25 08:16:36",
    "許可證字號": "衛署藥輸字第003104號",
    "註銷狀態": "已註銷",
    "註銷日期": "82\/11\/22",
    "註銷理由": "評估未獲通過",
    "製造許可登錄編號": "",
    "有效日期": "82\/11\/05",
    "發證日期": "63\/11\/05",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200310407",
    "中文品名": "胞嘧啶核\/雙磷酸膽鹼",
    "英文品名": "CYTIDINE-5&#39;-DIPHOSPHATE-CHOLINE &quot;WAKAMOTO&quot;",
    "適應症": "頭部外傷及腦手術所引起之意識障礙",
    "劑型": "040（粉）",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CITICOLINE (CDP-CHOLINECYTIDINE-5'-DIPHOSPHOCHOL",
    "限制項目": "02輸　入",
    "申請商名稱": "1414122100  嘉億企業股份有限公司",
    "申請商地址": "高雄縣烏松鄉？埔村大同路５之１號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0393000  WAKAMOTO PHARMACEUTICAL CO. LTD.",
            "製造廠廠址": "5-3, NIHONBASHI MUROMACHI 1-CHOME,CHUO-KU,TOKYO 103-8330    JAPAN5-3,NIHONBASHI, MUROMACHI 1-CHOME, CHUO-KU TOKYO, JAPAN.",
            "製造廠公司地址": "5-3,NIHONBASHI, MUROMACHI 1-CHOME, CHUO-KU TOKYO, JAPAN.",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2820000500",
            "成分名稱": "CITICOLINE (CDP-CHOLINECYTIDINE-5'-DIPHOSPHOCHOL",
            "含量描述": "97+",
            "含量": "",
            "單位": "%"
        }
    ]
}